Tafluprost / Timolol -- Benefit Assessment According to §35a Social Code Book V [Internet].

The aim of the present report was to assess the added benefit of the drug combination tafluprost / timolol in comparison with the appropriate comparator therapy (ACT) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical monotherapy with beta-blockers or prostaglandin analogues and require combination therapy and who would benefit from preservative-free eye drops.

http://ift.tt/2rvhZVF